As of 2024-12-13, the Relative Valuation of Revolution Medicines Inc (RVMD) is (91.69) USD. This relative valuation is based on P/E multiples. With the latest stock price at 44.93 USD, the upside of Revolution Medicines Inc based on Relative Valuation is -304.1%.
The range of the Relative Valuation is (93.98) - (94.39) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.9x - 39.8x | 34.8x |
| Forward P/E multiples | 19.3x - 28.0x | 19.6x |
| Fair Price | (93.98) - (94.39) | (91.69) |
| Upside | -309.2% - -310.1% | -304.1% |
| Date | P/E |
| 2024-12-12 | -13.33 |
| 2024-12-11 | -13.77 |
| 2024-12-10 | -14.03 |
| 2024-12-09 | -13.95 |
| 2024-12-06 | -14.26 |
| 2024-12-05 | -14.03 |
| 2024-12-04 | -14.31 |
| 2024-12-03 | -14.31 |
| 2024-12-02 | -15.37 |
| 2024-11-29 | -17.16 |
| 2024-11-27 | -17.38 |
| 2024-11-26 | -17.39 |
| 2024-11-25 | -17.06 |
| 2024-11-22 | -16.84 |
| 2024-11-21 | -16.84 |
| 2024-11-20 | -16.93 |
| 2024-11-19 | -16.75 |
| 2024-11-18 | -16.09 |
| 2024-11-15 | -16.35 |
| 2024-11-14 | -17.02 |
| 2024-11-13 | -17.24 |
| 2024-11-12 | -17.60 |
| 2024-11-11 | -17.98 |
| 2024-11-08 | -17.93 |
| 2024-11-07 | -17.53 |
| 2024-11-06 | -17.63 |
| 2024-11-05 | -16.84 |
| 2024-11-04 | -16.57 |
| 2024-11-01 | -16.34 |
| 2024-10-31 | -15.87 |
| 2024-10-30 | -14.98 |
| 2024-10-29 | -14.96 |
| 2024-10-28 | -14.17 |
| 2024-10-25 | -13.77 |
| 2024-10-24 | -14.02 |
| 2024-10-23 | -14.39 |
| 2024-10-22 | -13.98 |
| 2024-10-21 | -14.17 |
| 2024-10-18 | -14.96 |
| 2024-10-17 | -14.83 |
| 2024-10-16 | -14.96 |
| 2024-10-15 | -14.53 |
| 2024-10-14 | -14.60 |
| 2024-10-11 | -14.98 |
| 2024-10-10 | -14.68 |
| 2024-10-09 | -14.68 |
| 2024-10-08 | -14.76 |
| 2024-10-07 | -14.04 |
| 2024-10-04 | -14.04 |
| 2024-10-03 | -13.68 |